April 2017 Digital Edition

Click Here

March 2017 Digital Edition

Click Here

Feb. 2017 Digital Edition

Click Here

Nov/Dec 2016 Digital Edition

Click Here

Oct 2016 Digital Edition

Click Here

Technology Sectors

Market Sectors

CBRNE | Detection

FDA authorizes labs to use Zika detection kit by InBios

Seattle Aug. 19, 2016 InBios announced today that it received an Emergency Use Authorization (EUA) from the FDA for its ZIKV Detect™ IgM Capture ELISA. The product is intended for the presumptive detection of Zika virus IgM antibodies in human sera collected from individuals meeting CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria. This important diagnostic test kit contains all the necessary reagents to perform this assay and obtain results in four hours or less. Additional testing is required to confirm positive results from this assay.

The ZIKV Detect™ IgM Capture ELISA is not cleared or approved by the FDA. It is now available for use in laboratories in the United States that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories, as a part of a multi-test CDC recommended testing algorithm. As one of the conditions of authorization outlined by FDA, InBios will report any suspected false negative results of which it becomes aware to the FDA.

This test has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Wendy Bagnato, Senior Marketing Manager of InBios said, “One of the challenges with developing a serology kit for Zika is the likelihood of cross reactivity with other flaviviruses such as dengue. This can be a particular problem for patients living in or returning from areas where both Zika and dengue (or other flaviviruses) are endemic, making it difficult to determine the status of the patient. InBios’ kit has been designed to differentiate between the possibility of Zika virus and other flaviviruses, thus providing an important diagnostic tool for clinicians. We are very pleased to be able to offer this high quality kit in time to fill the critical demand in the US and its territories. We are acutely aware of the devastating effect this disease is having on pregnant women and believe this test will aid clinicians to diagnosis Zika virus infection faster.”

About Zika virus:

Zika virus is a disease which is spread to people primarily through the bite of an infected mosquito (Aedes aegypti and Aedes albopictus). The most common symptoms of Zika virus disease are fever, rash, joint pain, and red eyes. Other symptoms include muscle pain and headache. Many people infected with Zika virus won’t have symptoms or will have mild symptoms, which can last for several days to a week.

Complications:

An infected pregnant woman can pass Zika virus to her fetus during pregnancy or at the time of birth. Also, individuals infected with Zika virus can pass it to sex partners. Zika virus infection during pregnancy can cause a serious birth defect called microcephaly and other severe brain defects. Guillain-Barre syndrome (GBS), an uncommon sickness of the nervous system, is also very likely triggered by Zika virus infection in a small number of cases.

Recent Outbreaks:

Zika virus outbreaks may have occurred in many locations previously but have gone unrecognized because the symptoms are similar to other diseases such as dengue and chikungunya viruses. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infection in Brazil and on February 1, 2016, the World Health Organization (WHO) declared Zika virus a public health emergency of international concern (PHEIC). Local transmission has been reported in Americas, including recently in the United States. The U.S. has declared a Public Health Emergency in the U.S. territory of Puerto Rico due to the large number of ZIKA cases.

For more information on Zika virus, visit the CDC website: https://www.cdc.gov/zika/index.html

About InBios International, Inc.

InBios International, Inc., located in Seattle, WA, USA develops and manufactures high-quality proprietary diagnostic tests for infectious diseases. The facility is USDA licensed, FDA registered and ISO 13485:2003 Certified. InBios develops and markets a full range of diagnostic products affecting global public health including its FDA cleared Dengue Detect™ IgM Capture ELISA and West Nile Detect™ IgM Capture ELISA. The company also offers a full range of CE marked products including a Chikungunya ELISA kit. All products are manufactured in the USA.

Visit the InBios website: http://www.inbios.com.

Alpha Diagnostic International developing test kits to detect MERS viral infections

SAN ANTONIO Aug. 17, 2016 The Middle East Respiratory Syndrome (MERS) outbreak over the past several years has created an urgent need for diagnostic and therapeutic solutions. Alpha Diagnostic International, Inc. (ADI) has developed multiple ELISA test kits for screening MERS virus infections. These test kits will greatly enhance the ability to screen and quarantine humans and other animal species suspected of being infected by the MERS virus and become an important diagnostic tool for the health community as they work to combat further spread of the disease. For additional details on MERS-CoV related products, please visit: http://4adi.com/objects/catalog/product/extras/MERS_Vaccine_ELISA_Flr.pdf

MERS is a viral respiratory infection suspected to be derived from bats. MERS symptoms can range from asymptomatic to severe or even lethal. MERS infected individuals exhibit a high fatality rate with about a third of confirmed cases succumbing to death. What was first identified as an outbreak restricted to countries within the Arabian Peninsula has now shown up in several other Asian countries. The largest outbreak outside of Saudi Arabia was in South Korea in May of 2015 with 36 confirmed deaths and several thousand individuals quarantined. In total worldwide, there have been 1,791 confirmed cases of MERS-CoV, 640 MERS-CoV related deaths, and 27 affected countries.

“ADI has recognized the urgency and importance of developing diagnostic reagents to test for potential viral infection since the very first outbreak in the Middle East during 2012,” says Dr. Masarrat Ali, Scientific Director and President of ADI. “ADI has cloned and expressed various MERS recombinant proteins, made antibodies, and developed various ELISA kits to detect antibodies in animals and humans. ADI is the first company to introduce commercial ELISA kits to detect antibodies in humans, camels, and many other species,” added Dr. Ali.

The MERS ELISA kits developed by ADI allow for the testing of 96 samples using a single kit; each kit contains all reagents and positive and negative controls to perform the tests. These kits have been developed for testing samples in humans, camels, bats, pigs, cows, goats, and sheep. For each species, there are 3 different kits available for testing antibodies against nucleoprotein, spike protein 1, and spike protein 2.

About Alpha Diagnostic International, Inc.: ADI is a privately held, U.S. biotechnology company headquartered in San Antonio, Texas. ADI develops, manufactures, and supplies novel diagnostic and quality control reagents and test kits for use in basic biological and disease research in humans and animals. An important mission of ADI is to develop and supply diagnostic and validating solutions for promoting global health through improved vaccine therapeutics and mitigating the spread of human and animal diseases. For additional details, please visit: http://www.4adi.com.

Smiths Detection wins contract to provide detection systems at Egyptian airports

WIESBADEN, Germany Aug. 10, 2016 Smiths Detection has been awarded contracts worth almost £19m by Falcon Group to provide advanced detection systems for passenger checkpoint, hold baggage and cargo screening to airports across Egypt.

The award for X-ray scanners, people screening systems and trace detectors is part of national programme to provide an additional layer of security to existing equipment at airports. Smiths Detection systems were chosen by the Egyptian Ministry of Defence for their lifetime high performance and quality, as proven by earlier contracts.

The HI-SCAN 6040aTiX and HI-SCAN 6040-2is HR, which combine multi- or dual-view, high resolution imaging with sophisticated software to automatically detect explosives in carry-on baggage, will be deployed at security checkpoints. The innovative millimeter-wave eqo scanners, which can detect threat items of any material under clothing, will provide additional passenger screening. The recently launched IONSCAN 600, which detects and identifies explosives from traces found on baggage or clothing, will be deployed at passenger checkpoints and in hold baggage screening.

The contract also includes HI-SCAN 100100T-2is and HI-SCAN 145180-2is X-ray machines for screening oversized baggage and air cargo for explosives and other threats. Additional vehicle and cargo screening will be provided by the CIP-300 and HCVP Z60 car inspection X-ray portals and the mobile HCVMe35 for the inspection of loaded trucks and containers at airport entrances. Deliveries will be completed by August 2016.

Falcon Group is the main security supplier for Egypt and is in close relationship to the Military Intelligence which is a part of the Egyptian Ministry of Defence.

Tony Tielen, Regional Vice President EMEA, at Smiths Detection, said: “Enhancing aviation security through leading-edge technology is our top priority. With a broad portfolio of detection technologies, an excellent customer-orientated sales team and a strong local partner, ITI, we are proud to be a trusted partner of the Egyptian Ministry of Defence. The range of screening systems included in this contract will help provide world-class detection capabilities to protect against evolving threats.”

Smiths Detection offers advanced security solutions in civil and military markets worldwide, developing and manufacturing government-regulated technology products that help detect and identify explosives, chemical and biological agents, radiological and nuclear threats, weapons, narcotics and contraband. It is part of Smiths Group, a global leader in applying integrated, advanced technologies to markets in threat and contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.

Read all the latest news from Smiths Detection, follow us on LinkedIn at www.linkedin.com/company/smiths-detection, YouTube at www.youtube.com/user/smithsdetectiongroup, and Twitter at twitter.com/smithsdetection.

New feature in CISS mail screeners can detect narcotics

PITTSBURGH, Aug. 2, 2016 ChemImage Sensor Systems (CISS™) announced the launch of a new Presumptive Identification feature for their VeroVision™ Mail Screener product. The VeroVision Mail Screener, which was introduced to the corrections market in April 2015, is a non-contact imaging device designed to detect concealed narcotics that are sent through the mail to inmates. CISS will debut the VeroVision Mail Screener's presumptive identification capability at the upcoming American Correctional Association 146th Congress of Corrections in Boston, MA, from August 5th -10th, 2016. The VeroVison Mail Screener's current detection and new presumptive identification capabilities will be demonstrated at the CISS exhibit at booth #405.

The ChemImage VeroVision Mail Screener features a simple, one-click user interface that allows the operator to quickly and efficiently scan mail. Within seconds, the presence of an illicit drug and/or common cutting agent that may be hidden in a mail item is confirmed. And now, not only will the system detect the illicit material; it will give you a presumptive identification of what that material is. These detections/presumptive identifications are presented to the user in a simple interface which allows for report generation, inclusive of images.

In addition to demonstrating the Mail Screener's detection capability and officially introducing its Presumptive Identification capability, as a part of the expo, ChemImage Sensor Systems is hosting a hospitality event after sessions on Monday, August 8th, 2016 at Kings in Boston. Attendees to the expo have been invited to the CISS event for a fun-filled night of games, amusement, and other surprises to celebrate our continued success with the VeroVision Mail Screener and the launch of the Presumptive Identification feature.

For more information on the VeroVision Mail Screener product or ChemImage Sensor Systems you can visit them during the ACA conference or on their website www.cisensorsystems.com.

About ChemImage Sensor Systems

ChemImage Sensor Systems (CISS™) develops innovative standoff chemical imaging sensors that make our world healthier and safer by utilizing patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of drugs, chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens. For more information, visit www.cisensorsystems.com

ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art chemical imaging sensors make our world healthier and safer through many scientific applications, including defense, security, pharmaceuticals, forensic science and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems. For more information, visit www.chemimage.com

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Passport CEO tells Congress technology available to scan for radioactive materials

N. BILLERICA, MA July 20, 2016 Responding to questions raised during a congressional hearing on nuclear smuggling risks in the United States, Passport Systems, Inc. affirmed today that it has developed state-of-the-art radiation detection technology that can help domestic and foreign seaports thwart nuclear terrorists seeking to transport radioactive materials.

Robert Ledoux, President, CEO, and Director of Passport Systems, Inc., today offered reassurances to lawmakers concerned about whether effective and efficient cargo scanning technology is available. He said that Passport's advanced scanning technology can play a major role in protecting people and property in the U.S. and in foreign countries.

"At the hearing, subcommittee members cited the need for technology that can accurately detect nuclear threats and contraband without significantly slowing the shipping process," Dr. Ledoux said. "We have developed that technology and it is already being deployed at the port in Boston. It is ready to be deployed to other ports in the U.S. and internationally. Our SmartScan 3D™ cargo scanner can protect people and property from dirty bombs and other nuclear threats."

Dr. Ledoux said the SmartScan 3D system automatically identifies any radioactive material, including "actinides" that may signal a weapon of mass destruction or smuggled special nuclear materials, after the cargo has been unloaded onto conveyances. The non-intrusive cargo inspections also detect explosives and contraband such as drugs, tobacco, and firearms – a growing concern among security professionals and lawmakers.

The need for such technology was a focus of a joint hearing on July 7 by the House Transportation and Infrastructure Subcommittee on Coast Guard and Maritime Transportation and House Homeland Security Subcommittee on Border and Maritime Security. During the hearing, officials repeatedly testified that "gaps remain" in securing nuclear and radiological materials around the globe despite progress over the last 20 years, and acknowledged the challenges that the U.S. faces in protecting its ports from smuggled materials.

Jennifer Grover, Director of Homeland Security and Justice Issues at the Government Accounting Office, testified that "with about 12 million cargo shipments arriving each year in the U.S. – the U.S. maritime ports do indeed remain vulnerable to smuggling…CBP {U.S. Customs and Border Protection} has determined that it does not have the resources to examine every shipment. So instead what they are doing is counteracting the smuggling threat by identifying and examining at risk shipments. Yet ensuring this approach functions properly is indeed still a work in progress."

Passport will this fall unveil SmartScan at a first of its kind facility at the Massachusetts Port Authority, Port of Boston's Conley Container Terminal. The facility is part of a U.S. Department of Homeland Security, Domestic Nuclear Detection Office (DNDO) project under the Nuclear and Radiological Imaging Platform-Advanced Technology Demonstration project that was competitively awarded to Passport Systems in 2012.

"Safety and security are Massport's top priorities and we have worked closely with the Domestic Nuclear Detection Office, the US Coast Guard and Passport Systems to have Conley Terminal be on the cutting edge of detection,'' said Lisa Wieland, Massport's Port Director. "We will continue to embrace new technology to augment the existing systems that keep our ports safe.''

As noted at the subcommittee hearing, a limited X-ray scanning process is used at most ports today. Dense or thick objects, which could hide nuclear threats or contraband, require that individuals open the containers and inspect the objects by hand; it slows the shipping process by hours and the process could be dangerous for inspectors.

By contrast, SmartScan doesn't require that containers be opened. The technology scans a container, provides a three-dimensional map of the cargo, and sends alerts to flag suspicious cargo. Within minutes, it determines if an actinide is present and whether it is a bomb.

SmartScan works like this: Trucks leaving the port with cargo are conveyed through a 176-foot tunnel. The cargo is inspected using high-resolution x-rays and other passive radiation detection methods with proprietary technologies. Three-dimensional images based on the effective atomic number and density are generated as the system measures photon signals to determine anomalies, such as explosives or radioactive material. Additional technology determines if special nuclear materials are present.

At the hearing, Wayne Brasure, Acting Director of DNDO, noted that DNDO is developing and evaluating emerging technologies to detect shielded materials while clearing benign conveyances at land and maritime ports.

"One such effort is a project with the Massachusetts Port Authority, DHS Science and Technology's Border and Maritime Security Division, and the United Kingdom Home Office to develop and evaluate the next generation non-intrusive inspection imaging equipment," Mr. Brasure testified. "The technology will be evaluated in the Port of Boston next year and, if successful, will demonstrate a next generation integrated system capable of detecting both nuclear material and contraband."

Following the hearing, Dr. Ledoux noted that while utilizing the technology at other U.S. ports would increase security for the nation, it's also critical that foreign countries adopt comprehensive scanning technology at their ports since a key component of America's anti-smuggling strategy is to scan U.S.-bound cargo before it leaves foreign ports.

Mr. Brasure testified that efforts to "secure the homeland from the threat of nuclear terrorism begins overseas." He added that the security strategy relies "largely on the decisions of sovereign foreign partners to develop and enhance their own national and regional detection architectures."

Thus, Dr. Ledoux said that he and his colleagues at Passport are constantly meeting with foreign officials and international port security personnel to raise awareness of the availability of SmartScan.

"America needs to ensure that foreign governments are adopting the most comprehensive scanning equipment available," he said. "We are working to have SmartScan installed at ports around the world. That will make our country safer."

About Passport Systems

Passport Systems was founded to develop and commercialize new technologies to address the threats facing the world in the aftermath of the 9/11 terrorist attacks. Founded by a team of MIT technologists and entrepreneurs, Passport Systems has proudly developed two cutting-edge product lines: The SmartScan 3D™ Automated Cargo Inspection System, based on nuclear resonance fluorescence technology, and the SmartShield™ Networked Radiation Detection System, using advanced data fusion algorithms. For further details on Passport Systems and its products and services, please visit www.passportsystems.com.

PathSensors unveils new bio threat detection system

BALTIMORE, MD July 12, 2016 Baltimore-based biotech firm, PathSensors, Inc., announced today the launch of its Universal BioSensor technology. Developed in partnership with the University of Maryland School of Medicine, the Universal BioSensor is a new bio threat detection platform that can use any existing antibody to rapidly develop tests for the presence of pathogens in environmental samples. The Universal BioSensor expands the range of biological agents that PathSensor’s CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) biosensor can detect and significantly reduces development time cycles and costs.

“CANARY® technology has been proven to be superior for bio threat detection in terms of sensitivity, speed of detection, low false alarm rate and ease of use; with the development of the Universal BioSensor, CANARY® now has advantages over alternatives in terms of the number of pathogens it can detect,” commented PathSensors' CEO, Ted Olsen. “In addition, the Universal BioSensor makes it faster and cheaper for us to quickly develop and deploy new bio sensors in response to new and emerging bio threats.”

Unlike prior approaches that required engineering of specific antibodies into the cell that can bind to a pathogen during the detection process, the Universal BioSensor is engineered to express a novel protein that can bind any commercially available antibody and signal within the cell in the presence of the pathogen.

The Universal BioSensor was developed by scientists at the University of Maryland’s School of Medicine, in collaboration with PathSensors, Inc. The project was funded in part by a grant from the State of Maryland.

Dan H. Schulze, Ph.D., Professor of Microbiology and Immunology, University of Maryland and lead scientist on the project commented: “This approach provides a novel platform for detection of pathogens. It makes it possible to utilize available reagents that can target pathogens or antigens for an almost endless range of possibilities.” Dr. Schulze continued: “This shows how science can be combined with PathSensor’s commercialization expertise to broadly expand the scope of pathogen testing.”

About PathSensors, Inc.

PathSensors is a leading biotechnology solutions and environmental testing company. PathSensors provides high speed – high sensitive pathogen and threat detection solutions for the defense, homeland security, public health, medical countermeasures, mail room screening, first responder, food processing and agricultural sectors. PathSensors’ innovative BioFlash and Zephyr detection systems use CANARY® technology licensed from the MIT-Lincoln Laboratory and are deployed by government and commercial agencies due to their speed, accuracy and ease-of-use. For more information, visit http://www.pathsensors.com.

GSN 2016 Airport, Seaport, Border Security Awards Winner: Symetrica, Inc – Winner, Best Nuclear/Radiation Detection Solution

Editor’s Note: Based on the exceptionally high quality of this year’s winning entries in our 2016 Airport, Seaport, Border Security Awards Program, GSN has committed to publish in-depth articles of twelve of the best entries in GSN’s Daily Insider and Airport, Seaport, Rail, Border Security Weekly over the next two weeks. Today’s Winning Entry, Symetrica Inc, of Southampton, UK and Maynard MA, was interviewed by Awards Lead Judge Chuck Brooks, who opened the interview with several questions for Jeff McCray of Symetrica, U.S.A.

Chuck Brooks: There are many challenges for detection of radiological substances at borders, ports, forward bases and special events. These include ease or use, scalability, mitigating rates of false positives, and most importantly, the effectiveness of science inside the technologies. How would you describe Symetrica’s abilities to meet those challenges and be a differentiator in the security marketplace?

Jeff McCray: Symetrica technology uses enhanced detection systems, new and improved algorithms and, because we build in collaboration and diagnostics, we provide new capabilities that significantly reduce operational costs while have much lower through life costs.

We’ve delivered differentiation across a range of products from handheld isotope identifiers to our award winning Radiation Portal Monitors. Our technology is at the heart of Smith Detection’s high profile RadSeeker handheld radiation detectors for which the DHS Domestic Nuclear Detection Office (DNDO) recently awarded an IDIQ (indefinite delivery/indefinite quantity) contract with a maximum value of $143 million for the technology, its maintenance and associated training. This success has been built on exhaustive output from customers around operational challenges, government radiological test campaigns and large scale operational deployments. The Radseeker is on record as having been very well received by US CBP (Customs and Border Protection) while reducing false positive rates under operational conditions. In Radiation Portal Monitors our technology has again delivered differentiation in the market. The same approach of detector enhancement and algorithm development has been shown to significantly reduce the operational costs associated with nuisance or false alarms from NORM (Naturally Occurring Radioactive Material) normally associated with radiation portal monitors while delivering the same benefit of low through life cost.

Chuck Brooks: It is one measure to have the ability to detect and another to have the command, control and analytics integrated with the detection devices in different environments. What are Symetrica’s specific solutions tailored toward the stakeholders in these areas?

Jeff McCray: Symetrica has tailored a technological solution that seamlessly integrated into both legacy and state-of-the-art command and control infrastructures. This too has enabled s to provide new capabilities to customers directly and through the market leading prime partners as illustrated by the success of our handhelds, mobiles and portals with prime partners such as Smiths Detection and L3 security and Detection Systems. The key for us has been the delivery of a rigorously defined data interface for all our systems. This has enabled the host application or command system to display the required radiological data at the point of decision. We have also adopted industry standard data formats to deliver seamless integration under the hood and summary data directly to users. Combining this with a modular technology portfolio enables us to maximize the value of our offering against multiple requirements simultaneously.

Chuck Brooks: Symetrica has developed a wide spectrum of innovative threat verification security solutions. Can you further elaborate on your full product portfolio of handheld devices to fixed andMobile radiation monitors (RPMs) currently and in your future pipeline?

Jeff McCray: Our vision is to provide a wide ranging product portfolio that supports multiple security missions and nuclear markets. These include homeland security, CBRNe, first response and wider nuclear security challenges such as securing cities and military operations. We have an extensive portfolio of IP (Intellectual property) and excellent partners with whom we are developing the next generation of solutions to build on the success of our handhelds, mobiles and RPMs. We are currently trailing a new range of wearable detection systems and backpacks and will be launching these in the very near future.

The comprehensive and highly targeted awards program selected winners that “deal with very serious national and international threats in land, sea and air that are in the news every day” according to lead judge Chuck Brooks.

Symetrica’s winning entry, he added, was based upon the market-leading Discovery TechnologyTM contained in Symetric’s Radiation Portal Monitors (RPM). This polyvinyl-toluene (PVT) based technology delivers superior performance to increase operational efficiency by accurately discriminating between threat and non-threat materials, significantly reducing nuisance alarms.

Discovery RPM’s effectiveness has been demonstrated in field tests and operational deployment. A primary screening PVT RPM at the Port of Antwerp, for example, reduced innocent alarms from naturally occurring radioactive material (NORM) by 84%, decreasing disruption to the flow of commerce.

Symetrica’s Discovery Technology is deployed in over 1,000 systems globally, from handheld detectors to portal monitors. The current technology of choice for the United States Customs and Border Protection agency (CBP) based on competitive evaluations, Discovery Technology is the detection sub-system of the Smiths Detection RadSeeker handheld radiation detector for which the US Government Department of Homeland Security (DHS) Domestic Nuclear Detection Office (DNDO) recently awarded an IDIQ (indefinite delivery/indefinite quantity) contract with a maximum value of $143 million.

Commenting on Symetrica and other Winners in the program, Adrian Courtenay, CEO of the awards sponsor Government Security News commented, “There are some truly spectacular entries in this year’s program” and went on to call out Symetrica among the “New powerhouse winners.”

Commenting on the news, Jeff McCray, Symetrica, Inc’s VP of Business Development, said: “We are very honored to be selected to win this important category in such a prestigious awards program. Alongside the government technical evaluations and commercial success of Discovery Technology, it is very gratifying to be selected in this way, alongside some very strong competition.”

About Symetrica

As a global leader in radiation, detection and identification, Symetrica is uniquely positioned to provide the best cost effective radiation detection solutions to the Homeland Security Market. With extensive commercial expertise and a commitment to the delivering disruptive capabilities, Symetrica provides outstanding solutions for customs, border protection, law enforcement, emergency services, military personnel and first responders.

The company was established by Dr. Matthew Dallimore, Dr Grant Crossingham, Dr David Ramsden and Dr. Brian Lever in 2002 to commercialize high performance gamma-ray spectrometers as a spin out from the Department of Physics and Astronomy at the University of Southampton. Since then Symetrica research and development have provided operational solutions to many real world detection and identification challenges, work that has culminated in over 1000 fielded detection systems and an unencumbered patent portfolio. Symetrica established the North American technology and manufacturing center in Maynard, Massachusetts in 2005 to support our partners and the United States government. The location builds gamma and neutron detector subsystems for the RadSeeker and is the development and production center for the VeriFinder. Symetrica Discovery Technology® brand is distributed worldwide on Symetrica products and is incorporated as OEM solutions in equipment from our commercial partners. 

Specialties

Radiation Detection, Isotope Identification, Neutron Detection, Radiation Portal Monitors, Nuclear Safeguards, Civil Nuclear Supply Chain, Nuclear Medicine, Neutron Dosimetry, Military Radiation Detection, Mobile Detection, Active Interrogation.

The staff of Government Security News, Lead Sponsor HID GLOBAL and Lead Judge Chuck Brooks congratulate Symetrica, Inc as 2016 Winner in the category of “Best Nuclear/Radiation Detection category in the GSN 2016 Awards and wish the company many more years of brilliant success!

Block MEMS selected by Air Force for chemical detection contract

MARLBOROUGH, MA, July 6, 2016 Block MEMS, a leading developer of Quantum Cascade Laser (QCL) based infrared detection systems, has been awarded a $9.8M contract from the Intelligence Advanced Research Projects Activity (IARPA) to develop a system that can detect trace quantities of chemicals at standoff distances of at least 100 ft. The award is part of IARPA's Standoff Illuminator for Measuring Absorbance and Reflectance Infrared Light Signatures (SILMARILS) program and is managed by the U.S. Air Force Research Laboratory at Wright-Patterson Air Force Base, Ohio.

Dr. Anish Goyal, Block's VP of Technology and Principal Investigator of the contract, commented, "Standoff detection of trace chemicals, such as explosive residues, chemical warfare agents and toxic industrial materials, is a critical unmet need within the Intelligence Community, Department of Defense, and Department of Homeland Security. There are also many commercial applications for sensitive, standoff chemical detection.  Block's QCL technology combined with advanced data analytics makes it possible to meet the challenging performance goals of the SILMARILS Program."

Under this contract, Block will develop a new class of widely tunable, high-pulse energy Quantum Cascade Lasers and also next-generation detection algorithms to detect and identify hundreds of chemicals on a wide range of surfaces. Block has previously been successful in demonstrating standoff chemical detection capability under several prior government programs and this award will significantly advance the technology for use in real-world situations.

Dr. Petros Kotidis, CEO of Block, added, "Block is very pleased to receive this award and grateful to IARPA for their confidence in our technologies and products. Block has strong capabilities in developing sophisticated standoff chemical detectors and deep, decades-long understanding of infrared spectroscopy. We really look forward to expanding the operating envelope of our chemical detection systems through this award and providing more tools to the intelligence community and to the warfighter."

About Block MEMS LLC

Block MEMS, LLC is an engineering and development company focusing on the R&D of high performance Quantum Cascade Lasers (QCLs) and FTIR spectrometers. Block MEMS has been awarded numerous government contracts over the past decade for the application of its technologies toward the detection of explosives, buried IEDs, chemical warfare agents, toxic industrial materials and chemical clouds. Both standoff and sampling systems have been developed and delivered to the government for additional testing and evaluation. For example, Block's PORTHOS (TM) is a man-portable, passive FTIR spectrometer system that remotely detects chemical threats as far as three miles away and protects against chemical warfare agents and weapons of mass destruction. LaserWarn (TM) is a QCL-based system that is used to protect critical facilities against chemical attacks by establishing a "chemical trip-wire" using eye-safe laser beams.

About Block Engineering, LLC

Founded in 1956, Block Engineering, LLC is a leading manufacturer and marketer of high performance Quantum Cascade Laser and Fourier Transform Infrared analyzers and spectrometers for commercial, industrial, military and government customers. Block's unique QCL-based analyzers include the LaserSense (TM) Gas Analyzer for the detection and quantification of a wide variety of gases for process control and field applications in the oil, gas and chemical industries. In addition, the LaserWarn (TM) Gas Analyzer is used for safety, environmental, and fence-line monitoring of toxic and fugitive gases over a large area. The LaserTune (TM) product line of QCL-based Infrared Sources is used for corporate research and academic markets.

Implant Sciences wins contract to furnish detection equipment at Canadian airports

WILMINGTON, MA June 28, 2016 Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced that it was awarded a Standing Offer from the Canadian Air Transport Security Authority (CATSA) for up to 340 of its industry-leading QS-B220 desktop explosives trace detectors. These systems are to be deployed over the course of approximately the next two years to Canadian airports for passenger and baggage screening.

Implant Sciences' ETDs have been deployed to more than 160 airports over the last year. This order is in addition to the QS-B220 win last year of CATSA's competitive bid for 112 ETDs.

"Our robust systems, continue to be deployed in airports globally, deliver highly accurate and effective screening to the traveling public," stated Todd Swearingen, General Manager, Americas for Implant Sciences. "We pride ourselves in supporting the mission of safeguarding passengers around the world, and we are excited to have been selected again by CATSA."

"Our goal, as the pioneers of non-rad ETD, is to advance our products to meet the evolving needs of our customers and to surpass the performance and detection limitations of legacy trace detectors that are currently fielded," added Dr. Darryl Jones, Implant Sciences' Executive Vice President. "Implant Sciences' market share capture continues in North America and in the rest of the world. High-profile customers, like CATSA, repeatedly selecting our ETD solutions is the strongest endorsement we can receive."

About the QS-B220 Desktop Explosives Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint". For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

BPSI adds chemical detection system to New York landmark

SAN FRANCISCO, June 28, 2016 Building Protection Systems, Inc. (BPSI) announced today that they have successfully brought its Building Sentry One™ Chemical Detection System online at another undisclosed downtown Manhattan Iconic landmark building.

The extensive multi-sensor Sentry One™ platform was engineered as a retrofit project and seamlessly plugged into the existing Building Management System (BMS) and security platform without major changes to the existing infrastructure. "There is a mounting and sustained drive by thought-leading building owners to add protections against the huge risks associated with a Targeted Toxic Industrial Chemical Attack or Radiological Dirty Bomb release. It is akin to the early adopters of building sprinkler systems prior to the tragic Triangle Factory Fires in 1911 where it took an actual fire and large loss of life to push owners to adopt building sprinkler systems." says Greg Eiler, BPSI's President at BPSI. "We are also seeing a security shift to include physical fixed detection at potential target locations alongside the focus of cyber-threats to protect data. The basis of this shift is the very real awareness of the vulnerability of a building's air handling system and the lone-wolf scenarios targeting innocent people via an airborne toxic release into the HVAC," Mr. Eiler continues.

"We are very concerned with the current state of unrest in the world today and the focus of harm to the western world and our way of life. These detection protections answer deeply to several of our security concerns," says an undisclosed security expert about the installation. "The safety and security of people within their work environment is paramount. With detection, proven reliability and relative simplicity of the system is very important because false alarms cause a 'cry wolf' outcome. BPSI's type of detection goes well beyond traditional air monitoring and has easily replaced less reliable first generation detector systems that yielded high false alarm rates," says Mike Welden, SVP of Homeland Security for BPSI.

About BPSI

BPSI is the world leader in reliable automated toxin protection life-safety systems for public gathering spaces, mass transit stations, and buildings. Founded by building systems experts with over 30 years of infrastructure experience, BPSI's products are Qualified Anti-Terrorist Technologies (QATT) that quickly and reliably detect, identify and isolate toxic chemicals and radioactive isotopes in the air to protect innocent people and assets. More information can be found at www.bpsiglobal.com or 888-888-BPSI.

Pages

 

Recent Videos

HID Global is opening the door to a new era of security and convenience.  Powered by Seos technology, the HID Mobile Access solution delivers a more secure and convenient way to open doors and gates, access networks and services, and make cashless payments using phones and other mobile devices. ...
Mobile device forensics can make a difference in many investigations, but you need training that teaches you how to get the most out of your mobile forensics hardware and software, and certifies you to testify in court. Read this white paper to learn how to evaluate mobile forensics training...
PureTech Systems is a software company that develops and markets PureActiv, its geospatial analytics solution designed to protect critical perimeters and infrastructure.  Its patented video analytics leverage thermal cameras, radars and other perimeter sensors to detect, geo-locate, classify, and...
PureTech Systems is a technology leader in the use of geospatial video, focusing on perimeter security.  When combining geospatial capabilities with video analytics and PTZ camera control, managers of critical facilities can benefit by allowing the video management system to aid them in the process...